Personalizing the Selection of Systemic Therapies for Moderate-to-Severe Atopic Dermatitis
Podcast 4: Systemic Therapies for Moderate-to-Severe Atopic Dermatitis – Which to Use Whe
Pre-test
Exit Survey
Questions marked with a
*
are required
100%
Contact Information
First Name
Last Name
Email Address
When managing AD:
Shared decision making is optional
Patient discussions about conjunctivitis with monoclonal antibodies should always be done
Response to topical therapy for a flare may take 2-3 months
All of the above
A 22 y/o maintained on TCI, after failing TCS, has had monthly flares for last 3 months controlled with oral prednisone. Additional treatment options?
Phototherapy
Dupilumab or tralokinumab
JAK inhibitors
All of the above
Done
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close